Neuraxial Anesthesia for Surgery
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores two types of anesthesia for individuals undergoing surgery to improve leg blood flow. It compares neuraxial (spinal or epidural) anesthesia with general anesthesia regarding surgical outcomes. Participants will assist researchers in determining the best approach for a larger future study. The trial seeks individuals scheduled for leg artery surgeries who can access a phone for follow-up. As an unphased trial, it offers participants the chance to contribute to foundational research that could influence future surgical practices.
Will I have to stop taking my current medications?
The trial information does not specify if you need to stop taking your current medications. However, if you are on anticoagulants, they may need to be held for a certain period based on guidelines.
What prior data suggests that neuraxial anesthesia is safe for lower limb revascularization surgery?
Research has shown that neuraxial anesthesia, which includes spinal and epidural anesthesia, is generally safe and well-tolerated. One study of 1.7 million cases found the risk of a spinal hematoma (a blood clot near the spine) to be very low, about 1 in 200,000 for young women receiving an epidural during childbirth.
Another study found that spinal anesthesia might lower the risk of sudden kidney problems compared to general anesthesia, suggesting it could be a safer choice for some patients. Although rare complications like spinal epidural hematoma can occur, these are uncommon.
Overall, neuraxial anesthesia has a strong safety record, and many patients undergo these procedures without serious issues.12345Why are researchers excited about this trial?
Researchers are excited about neuraxial anesthesia for surgery because it offers a targeted approach to pain management that can minimize the need for systemic medications, like opioids, which are common in general anesthesia. Unlike general anesthesia, which affects the whole body, neuraxial anesthesia acts directly on the nerves around the spinal cord, potentially leading to fewer side effects like nausea and a faster recovery. Additionally, it allows for more personalized care, as anesthesiologists can choose between spinal, epidural, or a combination of both techniques, tailoring the anesthesia to the patient's specific needs. This flexibility and targeted approach could improve patient outcomes and enhance recovery times, making it a promising alternative to the traditional general anesthesia used in surgeries.
What evidence suggests that neuraxial anesthesia is effective for lower limb revascularization surgery?
Research has shown that neuraxial anesthesia, which includes spinal and epidural anesthesia, may offer several advantages over general anesthesia for surgery. In this trial, participants in the intervention arm will receive neuraxial anesthesia, while those in the control group will receive general anesthesia. Studies have found that neuraxial anesthesia can lead to a shorter hospital stay and less pain after surgery. Specifically, for surgeries on the lower limbs, such as revascularization, neuraxial anesthesia has been linked to a lower risk of death within 30 days post-operation. It may also reduce complications like lung and kidney problems, blood clots, and the need for blood transfusions. These findings suggest that neuraxial anesthesia can improve recovery and outcomes for patients undergoing certain surgeries.16789
Who Is on the Research Team?
Daniel McIsaac, MD
Principal Investigator
The Ottawa Hospital
Are You a Good Fit for This Trial?
The ALOFT Pilot Trial is for adults over 18 who are scheduled for lower limb revascularization surgery, like arterial bypass or angioplasty. Participants need to be able to use a phone for follow-up. It's not specified who can't join the trial.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo lower limb revascularization surgery with either neuraxial or general anesthesia
Follow-up
Participants are monitored for safety and effectiveness after surgery, including assessments at 30 days, 90 days, and 1 year
Extension
Long-term follow-up to assess health-related quality of life and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Neuraxial Anesthesia
Neuraxial Anesthesia is already approved in European Union, United States, Canada, Japan for the following indications:
- Lower limb revascularization surgery
- Pain management
- Lower limb revascularization surgery
- Pain management
- Obstetric procedures
- Lower limb revascularization surgery
- Pain management
- Lower limb revascularization surgery
- Pain management
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ottawa Hospital Research Institute
Lead Sponsor
The Ottawa Hospital Academic Medical Association
Collaborator
Canadian Institutes of Health Research (CIHR)
Collaborator
University of Ottawa
Collaborator